Skip to main content
SpringerLink
Log in

Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The non-invasive diagnosis of renal osteodystrophy (ROD) in patients with end-stage renal disease (ESRD) remains dependent on the determination of an accurate parathyroid hormone (PTH) level. Older assays that determine the “intact” PTH molecule are known to cross react with various PTH fragments, resulting in overestimation of PTH levels. Recently, assays that determine the whole 1-84 PTH molecule have been made available. Monthly PTH values in chronic dialysis patients at our institution were compared using the Nichols Bio-Intact PTH (BiPTH, 1-84 PTH) and the intact PTH (iPTH) assay over 3 consecutive months. One hundred twenty-four samples were obtained from 51 (29 male) pediatric dialysis patients (27 HD). The mean patient age was 14.2±5.6 years (1.8–25.7 years), with 12 patients<10 years and 15 patients <30 kg. The mean 1-84 PTH/iPTH ratio was 0.48±0.11. While BiPTH values correlated closely with iPTH values ( r =0.98, P <0.05), we observed significant intra-patient (16.4±15.4%; range: −73.9 to 67.7%, total % error: 47.2%) and inter-patient (17.2±18.9%; range: −73.9 to 129.9%, total % error: 55%) variability in the 1–84 PTH/iPTH ratio over the 3-month study period. Thus, our findings suggest that ROD management based on prior associations between iPTH levels and bone biopsy findings should not be extrapolated using the newer 1-84 PTH assay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607–617

    Google Scholar 

  2. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO (4), Ca x PO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131–2138

    Google Scholar 

  3. Block GA, Port FK (2000) Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 35:1226–1237

    Google Scholar 

  4. Salusky IB (1995) Bone and mineral metabolism in childhood end-stage renal disease. Pediatr Clin North Am 42:1531–1550

    Google Scholar 

  5. Martin KJ, Akhtar I, Gonzalez EA (2004) Parathyroid hormone: new assays, new receptors. Semin Nephrol 24:3–9

    Google Scholar 

  6. Brossard JH, Yamamoto LN, D’Amour P (2002) Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications. Semin Dial 15:196–201

    Google Scholar 

  7. von Lilienfeld-Toal H, Gerlach I, Klehr HU, Issa S, Keck E (1982) Immunoreactive parathyroid hormone in early and advanced renal failure. Nephron 31:116–122

    Google Scholar 

  8. Slatopolsky E, Hruska K, Rutherford WE (1975) Current concepts of parathyroid hormone and vitamin D metabolism: perturbations in chronic renal disease. Kidney Int [Suppl]:90–96

  9. Slatopolsky E, Martin K, Morrissey J, Hruska K (1982) Current concepts of the metabolism and radioimmunoassay of parathyroid hormone. J Lab Clin Med 99:309–316

    Google Scholar 

  10. Hruska KA, Kopelman R, Rutherford WE, Klahr S, Slatopolsky E, Greenwalt A, Bascom T, Markham J (1975) Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J Clin Invest 56:39–48

    Google Scholar 

  11. Hruska K, Kopelman R, Rutherford WE, Greenwalt A, Klahr S, Slatopolsky E (1975) Parathyroid hormone (PTH) metabolism in chronic renal disease (CRD). Proc Eur Dial Transplant Assoc 11:457–464

    Google Scholar 

  12. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753–761

    Google Scholar 

  13. Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, Fischer MS, Lifrieri F, Manni M, Morosetti M, Moscaritolo E, Sardella D (2002) PTH 1-84 and PTH “7-84” in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40:38–354

    Google Scholar 

  14. Goodman WG (2003) New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure. Kidney Int [Suppl]:S120–124

  15. Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH (2001) Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 60:1460–1468

    Google Scholar 

  16. Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Juppner H (2003) Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 63:1801–1808

    Google Scholar 

  17. Reichel H, Esser A, Roth HJ, Schmidt-Gayk H (2003) Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18:759–768

    Google Scholar 

  18. Waller S, Reynolds A, Ridout D, Cantor T, Gao P, Rees L (2003) Parathyroid hormone and its fragments in children with chronic renal failure. Pediatr Nephrol 18:1242–1248

    Google Scholar 

  19. Santamaria R, Almaden Y, Felsenfeld A, Martin-Malo A, Gao P, Cantor T, Aljama P, Rodriguez M (2003) Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays. Kidney Int 64:1867–1873

    Google Scholar 

Download references

Acknowledgements

We would like to acknowledge Spectra Laboratories and Karen Brock (Spectra Laboratory) for their support in this study.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA

    Rita D. Sheth & Stuart L.Goldstein

  2. Texas Children’s Hospital, 6621 Fannin Street MC 3-2482, Houston, TX, 77030, USA

    Rita D. Sheth

Authors
  1. Rita D. Sheth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stuart L.Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rita D. Sheth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheth, R.D., L.Goldstein, S. Comparison of 1-84 and intact parathyroid hormone assay in pediatric dialysis patients. Pediatr Nephrol 20, 977–981 (2005). https://doi.org/10.1007/s00467-005-1862-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-005-1862-4

Keywords

Search

Navigation